{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:22:45Z","timestamp":1791876165958,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.urolonc.2004.04.014","type":"journal-article","created":{"date-parts":[[2004,7,28]],"date-time":"2004-07-28T10:40:33Z","timestamp":1091011233000},"page":"353-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prostate cancer screening: Clinical applications and challenges\u2606"],"prefix":"10.1016","volume":"22","author":[{"given":"Otis W","family":"Brawley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2004.04.014_BIB1","doi-asserted-by":"crossref","first-page":"915","DOI":"10.7326\/0003-4819-137-11-200212030-00013","article-title":"Screening for prostate cancer","volume":"137","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0889-8588(05)70314-2","article-title":"Cancer screening","volume":"14","author":"Kramer","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/jama.1995.03520280035036","article-title":"A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer","volume":"273","author":"Gann","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0090-4295(01)01264-X","article-title":"Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria","volume":"58","author":"Bartsch","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB5","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/jnci\/90.16.1230","article-title":"Prostate cancer incidence and mortality in the United States and the United Kingdom","volume":"90","author":"Shibata","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/bmj.325.7367.740","article-title":"Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut","volume":"325","author":"Lu-Yao","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ijc.1260","article-title":"International trends in prostate-cancer mortality in the \u201cPSA ERA\u201d","volume":"92","author":"Oliver","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1097-0045(19990201)38:2<83::AID-PROS1>3.0.CO;2-B","article-title":"Screening decreases prostate cancer death","volume":"38","author":"Labrie","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1464-410X.2003.04306.x","article-title":"Screening for prostate cancer","volume":"92","author":"Boyle","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/(SICI)1097-0045(19990701)40:2<135::AID-PROS11>3.0.CO;2-Y","article-title":"Reply to Labrie et al. Results of the mortality analysis of the Quebec Randomized\/controlled trial (RCT)","volume":"40","author":"Alexander","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB11","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1200\/JCO.2001.19.6.1619","article-title":"Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer","volume":"19","author":"Madalinska","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB13","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/jnci\/94.13.958","article-title":"Understanding and appreciating overdiagnosis in the PSA era","volume":"94","author":"Yao","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB14","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jnci\/94.13.981","article-title":"Overdiagnosis due to prostate-specific antigen screening","volume":"94","author":"Etzioni","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB15","series-title":"Probability of Developing or Dying of Cancer Software, Version 5.0","year":"1999"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB16","doi-asserted-by":"crossref","first-page":"917","DOI":"10.7326\/0003-4819-137-11-200212030-00014","article-title":"Screening for prostate cancer","volume":"137","author":"Harris","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB17","first-page":"27","article-title":"American Cancer Society guidelines for the early detection of cancer, 2003","volume":"53","author":"Smith","year":"2003","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1022216119066","article-title":"Prostate cancer in black and white Americans","volume":"22","author":"Reddy","year":"2003","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0022-5347(05)64662-9","article-title":"Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy","volume":"168","author":"Bianco","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB20","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/cncr.10535","article-title":"Prostate specific antigen progression after radical prostatectomy in African-American men versus white men","volume":"94","author":"Banerjee","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0360-3016(97)00835-3","article-title":"The study of untreated syphilis in the negro male","volume":"40","author":"Brawley","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB22","first-page":"184","article-title":"Prostate cancer and black men","volume":"16","author":"Brawley","year":"1998","journal-title":"Semin Urol Oncol"},{"key":"10.1016\/j.urolonc.2004.04.014_BIB23","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0090-4295(01)01434-0","article-title":"l: Treatments for prostate cancer in older men: 1984\u20131997","volume":"58","author":"Bubolz","year":"2001","journal-title":"Urology"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143904000870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143904000870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:51:11Z","timestamp":1761040271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143904000870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S1078143904000870"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2004.04.014","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate cancer screening: Clinical applications and challenges\u2606","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2004.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}